Key result
Removal of a single LSR allele in mice caused significant increases in plasma triglyceride and cholesterol levels and delayed clearance of lipid emulsions.
Answers are grounded in this paper and cite their sources.
LSR plays a critical role in the physiological clearance of atherogenic triglyceride-rich lipoproteins and LDL, suggesting it as a potential therapeutic target for hyperlipidemia.
The lipolysis-stimulated lipoprotein receptor, LSR, is a multimeric protein complex in the liver that undergoes conformational changes upon binding of free fatty acids, thereby revealing a binding site (s) that recognizes both apoB and apoE. Complete inactivation of the LSR gene is embryonic lethal in mice. Here we show that removal of a single LSR allele (LSR(-/+)) caused statistically significant increases in both plasma triglyceride and cholesterol levels, a 2-fold increase in plasma triglyceride changes during the post-prandial phase, and delayed clearance of lipid emulsions or a high fat meal. The longer postprandial lipoprotein clearance time observed in LSR(-/+) mice was further increased in LSR(-/+) mice lacking functional low density lipoprotein (LDL) receptors. LSR(-/+) mice placed on a Western-type diet displayed higher plasma triglycerides and cholesterol levels, increased triglyceride-rich lipoproteins and LDL, and increased aorta lipid content, as compared with control mice on the same diet. Furthermore, a direct correlation was observed between the hyperlipidemia and weight gain but only in the LSR(-/+) mice. Knockdown of LSR expression by small interfering RNA in mouse Hepa1-6 cells led to decreased internalization of both DiI-labeled cyclohexanedione-LDL and very low density lipoprotein in the presence of oleate. These data led us to conclude that LSR contributes to the physiological clearance of atherogenic triglyceride-rich lipoproteins and LDL. We propose that LSR cooperates with the LDL receptor in the final hepatic processing of apoB-containing lipoproteins and represents a novel therapeutic target for the treatment of hyperlipidemia associated with obesity and atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Yen et al. (2008) studied Hyperlipidemia. Removal of a single LSR allele (LSR(-/+)) vs. Control mice was evaluated on Plasma triglyceride and cholesterol levels. Removal of a single LSR allele in mice caused significant increases in plasma triglyceride and cholesterol levels and delayed clearance of lipid emulsions.
Synapse has enriched 10 related papers. Consider them for comparative context: